In 2015, Donald E. Morel, Jr., Ph.D. earned $1.97M in total compensation at West Pharmaceutical Services, including $461.86K salary and $537.41K bonus. Most recently acquired 6,993 shares in Oct 2023. Currently holds stock worth $225.07M. Has donated $58.02M in stock to charitable causes. Led West Pharmaceutical Services as CEO for 10 years.
Compensation History
Annual executive compensation data for Donald E. Morel, Jr., Ph.D., including salary, bonuses, and stock awards.
Year
2015
Total Compensation
$1.97M
Salary
$461.86K
Bonus
$537.41K
Other
$965.79K
Salary
$461.86KBoard Justification
The compensation philosophy emphasizes alignment with shareholder interests and performance-based pay.
Bonus
$537.41KBoard Justification
Actual (above-target) bonus earned only for services as CEO and Chairman of the Board through June 30.
Other Compensation
$965.79KBoard Justification
Includes personal retirement benefits, payout of accrued vacation, and the transfer of his company vehicle.
Restricted Stock
Board Justification
No stock awards vested in 2015 as Dr. Morel's retirement was effective June 30, 2015.
Performance Metrics
Performance metrics for the AIP were based on adjusted diluted EPS and adjusted operating cash flow.
Donald E. Morel, Jr., Ph.D.
Ex-CEO of West Pharmaceutical Services
Education
Ph.D.
Sector of Economy
Healthcare
Born
June 1, 1951 - 74 years ago
CEO of West Pharmaceutical Services for
10 years 0 months (Jun 2005 - Jul 2015)
Previous Experience
Chairman and Chief Executive Officer
Other West Pharmaceutical Services CEOs
Holdings
Track Donald E. Morel, Jr., Ph.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$6.58M
$6.58M
140,000 WST shares
What if they kept their stock?
If Donald E. Morel, Jr., Ph.D. didn't sell their stock, today they would have:
Extra WST140,000 shares worth $39.45M.
This is 499.62% and $32.87M more than what they got when they sold the stock.
Charitable Transactions
205,900 shares
WST
Recent Charitable Transactions
15,000 shares
WST
Feb 26, 2015
Charity
750 shares
WST
Feb 5, 2015
Charity
9,300 shares
WST
Jan 12, 2015
Charity
10,000 shares
WST
Dec 9, 2014
Charity
5,000 shares
WST
Nov 12, 2014
Charity
11,000 shares
WST
Sep 26, 2014
Charity
Insider Trading
Donald E. Morel, Jr., Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.
6,993 shares
CTLT
Oct 27, 2023
Received
4,149 shares
CTLT
Oct 27, 2022
Received
1,402 shares
CTLT
Oct 28, 2021
Received
2,125 shares
CTLT
Oct 29, 2020
Received
661 shares
CTLT
Aug 27, 2020
Received
3,167 shares
CTLT
Aug 22, 2019
Received
$444.40K
CTLT at $44.44/share
May 15, 2019
Purchase
$430.00K
CTLT at $43.00/share
Sep 13, 2018
Purchase
4,183 shares
CTLT
Aug 23, 2018
Received
3,976 shares
CTLT
Aug 24, 2017
Received
Rivals
Compare Donald E. Morel, Jr., Ph.D. with competitor CEOs and industry peers.